| Christopher A Odehnal, MD | |
|
1000 E Primrose St, Springfield, MO 65807-5154 | |
| (417) 269-9812 | |
| (417) 269-9853 |
| Full Name | Christopher A Odehnal |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 4 Years |
| Location | 1000 E Primrose St, Springfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477046415 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2019030232 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Centers | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lester E Cox Medical Centers | 1254248917 | 262 |
News Archive
Precision medicine represents a revolution in health care. Doctors and researchers may soon be able to use the genetic profiles of patients to predict with great accuracy which treatment and prevention protocols will work for them.
Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.
Use it or lose it, fitness experts tell us. Now a new study offers evidence that the adage really does ring true – that a lack of exercise can not only cause physical setbacks, but also psychological setbacks as well.
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
› Verified 5 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538334396 PECOS PAC ID: 1254248917 Enrollment ID: O20050624000293 |
News Archive
Precision medicine represents a revolution in health care. Doctors and researchers may soon be able to use the genetic profiles of patients to predict with great accuracy which treatment and prevention protocols will work for them.
Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.
Use it or lose it, fitness experts tell us. Now a new study offers evidence that the adage really does ring true – that a lack of exercise can not only cause physical setbacks, but also psychological setbacks as well.
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
› Verified 5 days ago
| Entity Name | Lakeland Hospital Acquisition Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720165327 PECOS PAC ID: 6204960677 Enrollment ID: O20130925000626 |
News Archive
Precision medicine represents a revolution in health care. Doctors and researchers may soon be able to use the genetic profiles of patients to predict with great accuracy which treatment and prevention protocols will work for them.
Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.
Use it or lose it, fitness experts tell us. Now a new study offers evidence that the adage really does ring true – that a lack of exercise can not only cause physical setbacks, but also psychological setbacks as well.
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
› Verified 5 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669923884 PECOS PAC ID: 1254248917 Enrollment ID: O20161206000652 |
News Archive
Precision medicine represents a revolution in health care. Doctors and researchers may soon be able to use the genetic profiles of patients to predict with great accuracy which treatment and prevention protocols will work for them.
Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.
Use it or lose it, fitness experts tell us. Now a new study offers evidence that the adage really does ring true – that a lack of exercise can not only cause physical setbacks, but also psychological setbacks as well.
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
› Verified 5 days ago
| Entity Name | Cox-monett Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205387289 PECOS PAC ID: 0345236667 Enrollment ID: O20161213002029 |
News Archive
Precision medicine represents a revolution in health care. Doctors and researchers may soon be able to use the genetic profiles of patients to predict with great accuracy which treatment and prevention protocols will work for them.
Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.
Use it or lose it, fitness experts tell us. Now a new study offers evidence that the adage really does ring true – that a lack of exercise can not only cause physical setbacks, but also psychological setbacks as well.
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
› Verified 5 days ago
| Entity Name | Skaggs Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255870853 PECOS PAC ID: 5092624320 Enrollment ID: O20170310001975 |
News Archive
Precision medicine represents a revolution in health care. Doctors and researchers may soon be able to use the genetic profiles of patients to predict with great accuracy which treatment and prevention protocols will work for them.
Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.
Use it or lose it, fitness experts tell us. Now a new study offers evidence that the adage really does ring true – that a lack of exercise can not only cause physical setbacks, but also psychological setbacks as well.
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher A Odehnal, MD Po Box 802843, Kansas City, MO 64180-2843 Ph: (417) 730-6430 | Christopher A Odehnal, MD 1000 E Primrose St, Springfield, MO 65807-5154 Ph: (417) 269-9812 |
News Archive
Precision medicine represents a revolution in health care. Doctors and researchers may soon be able to use the genetic profiles of patients to predict with great accuracy which treatment and prevention protocols will work for them.
Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.
Use it or lose it, fitness experts tell us. Now a new study offers evidence that the adage really does ring true – that a lack of exercise can not only cause physical setbacks, but also psychological setbacks as well.
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
› Verified 5 days ago
Shalvinder Kaur Seehra, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3525 E Battlefield St, Springfield, MO 65809 Phone: 417-269-1499 Fax: 417-269-1459 | |
Harwinder K Dhanoa, Family Medicine Medicare: Medicare Enrolled Practice Location: 1540 E Evergreen St, Springfield, MO 65803 Phone: 417-823-2900 | |
Thomas E Dahlberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3322 S Campbell Ave Ste T-1, Springfield, MO 65807 Phone: 417-220-4480 Fax: 417-414-0017 | |
Dr. John H Brown, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 S National Ave, Suite 280, Springfield, MO 65807 Phone: 417-885-0834 Fax: 417-888-6763 | |
Dr. Jay L Sparks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 S National Ave, Suite 220, Springfield, MO 65807 Phone: 417-820-7450 Fax: 417-820-7455 | |
Dr. Conrad Mitchell Bajor, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1235 E Cherokee St, Springfield, MO 65804 Phone: 417-820-2600 | |
Dr. William Russell Detten, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1530 E Republic Rd, Springfield, MO 65804 Phone: 417-269-1362 Fax: 417-269-1372 |